[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Indena SpA - Strategic SWOT Analysis Review

March 2021 | 28 pages | ID: IBE7FE5ED24EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Indena SpA (Indena), a subsidiary of IdB Holding SpA is a provider of active ingredients. It identifies, develops and manufactures active principles derived from plants which find applications in pharmaceutical, health-food and personal care industries. It produces standardized extracts from plants, which are recognized to have therapeutic properties, and are proven to have pharmacological value. The company focuses on producing anti-cancer drugs in the area of pharmaceutical research. It also focuses on producing standardized botanical derivatives that form important ingredients in health food products. The company has sales operations across Italy, France, Brazil, the US, Japan and China; and production facilities in Italy, France and India. Indena is headquartered in Milan, Italy.

Indena SpA Key Recent Developments

May 26,2020: Indena announces the successful completion of the registration of Escin, in accordance with the REACH regulation
Feb 05,2020: Indena receives grant to optimise formulation of two Medicines For Malaria Venture compounds for children

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Indena SpA - Key Facts
Indena SpA - Key Employees
Indena SpA - Key Operational Employees
Indena SpA - Major Products and Services
Indena SpA - History
Indena SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Indena SpA - Business Description
Indena SpA - SWOT Analysis
SWOT Analysis - Overview
Indena SpA - Strengths
Indena SpA - Weaknesses
Indena SpA - Opportunities
Indena SpA - Threats
Indena SpA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Indena SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Indena SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Indena SpA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 26, 2020: Indena announces the successful completion of the registration of Escin, in accordance with the REACH regulation
Feb 05, 2020: Indena receives grant to optimise formulation of two Medicines For Malaria Venture compounds for children

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Indena SpA, Key Facts
Indena SpA, Key Employees
Indena SpA, Key Operational Employees
Indena SpA, Major Products and Services
Indena SpA, History
Indena SpA, Subsidiaries
Indena SpA, Key Competitors
Indena SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Indena SpA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Indena SpA, Recent Deals Summary

LIST OF FIGURES

Indena SpA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Indena SpA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications